Asthma News

Patients with asthma preferred convenient management options that prioritized decreases in short-term morbidity over long-term goals, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Mepolizumab and benralizumab were associated with prolonged reductions in oral corticosteroid use among real-world patients with severe eosinophilic asthma, according to data in The Journal of Allergy and Clinical Immunology: In Practice.

Individual nation results from the Severe Asthma Index indicate that the disease remains inadequately prioritized around the world, according to an abstract presented at the European Respiratory Society International Congress.

More children with asthma who were treated with dupilumab than placebo met criteria as responders in percent predicted FEV1 measurements, according to an abstract presented at the European Respiratory Society International Congress.

By measuring specific IgE against Staphylococcus aureus enterotoxin, physicians may identify patients with more asthma exacerbations, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Electronic monitoring devices supported short-term adherence to asthma medication, with sustained improvements in asthma control, according to an abstract presented at the European Respiratory Society International Congress.

Children attending daycare centers with a dust microbiota profile of Streptococcus and Lactococcus faced an increased likelihood for wheezing, according to a presentation at the European Respiratory Society International Congress.

A multi-organizational panel has developed a working definition for clinical remission in asthma, according to a paper published in Annals of Allergy, Asthma & Immunology.

Patients with severe asthma achieved clinical remission based on a four-component definition with 52 weeks of mepolizumab, according to an abstract presented at the European Respiratory Society International Congress.

Adults with asthma who also had laryngeal hypersensitivity had a greater symptom burden during the 2019 to 2020 landscape fires in Australia, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.